Catalent Applies to Import Psilocybin for U.S. Market
Published Date: 3/4/2026
Notice
Summary
Catalent Greenville, Inc. wants to become an official importer of psilocybin, a controlled substance. This affects companies involved in drug manufacturing and importation, who can comment or request a hearing by April 3, 2026. No direct costs are mentioned, but the decision could impact the controlled substances market.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in